Discovery offers insight for development of cancer therapies targeting mutant p53

The tumor suppressor protein p53 is mutated in more than half of all human cancers. Several drugs that potentially can restore mutant p53 to its normal cancer-killing function are in clinical investigation.

source https://medicalxpress.com/news/2021-08-discovery-insight-cancer-therapies-mutant.html